Stage III Lip and Oral Cavity Cancer AJCC v8
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11105 | Benzalkonium | 1 | Suspended | 1 |
DB14547 | Chloride ion | 1 | Recruiting | 1 |
DB00515 | Cisplatin | 1 | Recruiting | 1 |
DB11743 | Ipatasertib | 1 | Recruiting | 1 |
DB16252 | Nedisertib | 1 | Suspended | 1 |
DB09037 | Pembrolizumab | 1 | Active Not Recruiting | 1 |
DB12257 | Platinum | 1 | Recruiting | 1 |
DB15375 | Tozuleristide | 1 / 2 | Recruiting | 1 |
DB08875 | Cabozantinib | 2 | Recruiting | 1 |
DB00958 | Carboplatin | 2 | Not Yet Recruiting | 1 |
DB14547 | Chloride ion | 2 | Not Yet Recruiting | 1 |
DB14547 | Chloride ion | 2 | Recruiting | 1 |
DB00515 | Cisplatin | 2 | Completed | 1 |
DB00515 | Cisplatin | 2 | Not Yet Recruiting | 1 |
DB00515 | Cisplatin | 2 | Recruiting | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 1 |
DB12257 | Platinum | 2 | Completed | 1 |
DB12257 | Platinum | 2 | Not Yet Recruiting | 1 |
DB12257 | Platinum | 2 | Recruiting | 1 |
DB09499 | Thiosulfuric acid | 2 | Completed | 1 |
DB16305 | Xevinapant | 2 | Not Yet Recruiting | 1 |
DB00002 | Cetuximab | 2 / 3 | Active Not Recruiting | 1 |
DB11714 | Durvalumab | 2 / 3 | Active Not Recruiting | 1 |